SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

被引：211

作者：

Kuster, Gabriela M. ^{[1
,2
,3
]}

Pfister, Otmar ^{[1
,2
,3
]}

Burkard, Thilo ^{[1
,4
]}

Zhou, Qian ^{[1
]}

Twerenbold, Raphael ^{[1
,5
]}

Haaf, Philip ^{[1
]}

Widmer, Andreas F. ^{[6
]}

Osswald, Stefan ^{[1
]}

机构：

[1] Univ Hosp Basel, Clin Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland

[2] Univ Hosp Basel, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland

[3] Univ Basel, Hebelstr 20, CH-4031 Basel, Switzerland

[4] Univ Hosp Basel, Hypertens Clin, Med Outpatient Clin, Petersgraben 4, CH-4031 Basel, Switzerland

[5] Univ Hosp Basel, Cardiovasc Res Inst Basel CRIB, Spitalstr 2, CH-4056 Basel, Switzerland

[6] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Petersgraben 4, CH-4031 Basel, Switzerland

来源：

关键词：

D O I：

10.1093/eurheartj/ehaa235

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1801 / 1803

页数：3